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Abstract
Tubulo-interstitial damage is a common finding in the chronically diseased kidney and is characterized by ongoing
inflammation and fibrosis leading to renal dysfunction and end-stage renal disease. Upon kidney injury, endogenous ligands
can be released which are recognized by innate immune sensors to alarm innate immune system. A new family of innate
sensors is the family of TREM (triggering receptor expressed on myeloid cell). TREM1 is an activating receptor and requires
association with transmembrane adapter molecule DAP12 (DNAX-associated protein 12) for cell signaling. TREM1-DAP12
pathway has a cross-talk with intracellular signaling pathways of several Toll-like receptors (TLRs) and is able to amplify TLR
signaling and thereby contributes to the magnitude of inflammation. So far, several studies have shown that TLRs play a
role in obstructive nephropathy but the contribution of TREM1-DAP12 herein is unknown. Therefore, we studied TREM1
expression in human and murine progressive renal diseases and further investigated the role for TREM1-DAP12 by
subjecting wild-type (WT), TREM1/3 double KO and DAP12 KO mice to murine unilateral ureter obstruction (UUO) model. In
patients with hydronephrosis, TREM1 positive cells were observed in renal tissue. We showed that in kidneys from WT mice,
DAP12 mRNA and TREM1 mRNA and protein levels were elevated upon UUO. Compared to WT mice, DAP12 KO mice
displayed less renal MCP-1, KC and TGF-b1 levels and less influx of macrophages during progression of UUO, whereas
TREM1/3 double KO mice displayed less renal MCP-1 level. Renal fibrosis was comparable in WT, TREM1/3 double KO and
DAP12 KO mice. We conclude that DAP12, partly through TREM1/3, is involved in renal inflammation during progression of
UUO.
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Introduction
Fibroproliferative diseases, including chronically kidney disease,
are a leading cause of morbidity and mortality and can affect all
tissues and organ systems [1]. Tubulo-interstitial damage is a
common finding in the chronically diseased kidney whereby the
degree of tubulo-interstitial damage is a major determinant of
renal function and outcome. Tubulo-interstitial injury is charac-
terized by infiltration of leukocytes and myofibroblast accumula-
tion with excessive deposition of extracellular matrix (ECM) [2–5].
As inflammation and interstitial fibrosis progress, tubular atrophy
occurs which leads to renal dysfunction and finally to end-stage
renal disease. Because the extent of fibrosis is an important
predictor for outcome, much research has been put into the
mechanisms behind this phenomenon. Unilateral ureteral ob-
struction (UUO) is a model frequently used in mice that mimics
features observed in tubulo-interstitial injury including influx of
leukocytes and accumulation of (myo)fibroblast followed by ECM
deposition and tissue loss [2–5]. During tissue injury, like in UUO,
damaged cells are able to elicit danger signals so called ‘danger-
associated molecular patterns’ (DAMPs). These DAMPs are
endogenous ligands which are able to alert the innate immune
system through recognition by pattern-recognition receptors
(PRR) including Toll-like receptors (TLRs) [6,7]. Recently, a
new family of receptors were discovered which share intracellular
signaling cascade of TLRs called TREM (triggering receptor
expressed on myeloid cell). TREM1 is an activating receptor
expressed on neutrophils, monocytes and some types of macro-
phages [8,9]. TREM1 lacks an intracellular signaling motif and
associates with its adaptor molecule TYROBP (commonly called
DAP12; DNAX-activating protein-12) to induce cytokine produc-
tion. No specific ligand for TREM1 has been found so far but
HMGB1, known to be increased following UUO, is a potential
candidate [10–13]. Besides its own direct intracellular signaling
cascade pathway, TREM1-DAP12 activation has a cross-talk with
intracellular signaling pathways of several TLRs and is able to
amplify TLR signaling and can thereby contribute to the
magnitude of inflammation. So far, several studies have shown
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that TLR2, TLR4 and their intracellular adopter molecule
MyD88 play part in mechanisms of renal fibrosis [11,12,14–16].
We hypothesis that TREM1-DAP12 signaling contributes to the
magnitude of inflammation during UUO. To our knowledge, no
studies about TREM1-DAP12 in renal injury or fibrosis are
known. We investigated localization of TREM1 in human kidneys
suffering from obstructive nephropathy. Subsequently, we inves-
tigated the contribution of TREM1-DAP12 in renal fibrosis by
subjecting wild-type, TREM1/3 KO and DAP12 KO mice to
UUO model.
Materials and Methods
Patients
Kidney samples were obtained from patients diagnosed with
terminal hydronephrosis characterized by extensive fibrosis and
tubular atrophy at the Academic Medical Center as described
before [11]. As control, we used a protocolar biopsy from a renal
transplant patient with stable graft function, obtained 6 months
after transplantation obtained from a cohort study at Academic
Medical Center as described [17]. All renal biopsies were taken for
diagnostic purposes only. This research project used only left-over
biological material, anonyms and delinked from patient records,
and as such was not subjected to any requirement for ethical
review or approval.
Mice
Pathogen-free 9 to 12-week old female WT C57Bl/6 mice were
purchased from Charles River Laboratories. TREM1/3 double
KO mice were generated as recently described before [18].
TREM1/3 double KO mice were generated because TREM1 and
TREM3 are highly homologous and likely to be redundant.
Because TREM3 is a pseudogene in humans, TREM1/3 double
KO mouse would more closely mimic human TREM1 deficiency.
TREM1/3 double KO mice (further referred to as TREM1/3
KO mice) were fully backcrossed to a C57Bl/6 background.
DAP12 KO mice backcrossed to C57bl/6 background were
generated as before [19]. TREM1/3 KO and DAP12 KO mice
were bred in the animal facility of the Academic Medical Center in
Amsterdam, the Netherlands. Sex and age matched mice were
used. The Animal Care and Use Committee of the University of
Amsterdam approved all experiments.
Unilateral Ureteral Obstruction
Progressive renal injury was induced by unilateral ureteral
obstruction (UUO) as described before [11,12,20–22]. Briefly, the
right ureter was ligated under 2% isoflurane-induced anesthesia.
After abdomen was closed, mice received a subcutaneous injection
of 50 mg/kg buprenorphin (Temgesic, Shering-Plough). Mice were
sacrificed 1, 3, 7 or 14 days after surgery. (Un)obstructed kidney
was divided for immunohistochemistry (paraffin) or snap-frozen in
liquid nitrogen for RNA and protein determination.
Immunohistochemistry
Human and murine renal tissue was fixed in 10% formalin and
embedded in paraffin. Tissue sections of kidney (4 mm) were dried
overnight and deparaffinized. Antigen retrieval, blocking of non-
specific binding, incubation with primary and secondary antibody
and development were performed as described before [11,12,20–
22]. For TREM1 immunohistochemistry, human renal tissue
section were pretreated with citrate buffer (10 mM Sodium
Citrate, pH 6.0), incubated with TREM1 antibody (Rabbit-anti
Human; Sigma HPA005563), followed by BrightVision Poly-
HRP-Anti Rabbit (Immunoligic) and developed using 1% H2O2
and DAB (Sigma) in 0.05 M Tris-HCl (pH 7.9). On mouse renal
sections, detection of macrophages (rat anti-mouse F4/80;
Serotec), granulocytes (rat anti-mouse Ly6/G-Fitc; Pharmingen),
a-smooth muscle actine (mouse-anti-human aSMA-IgG2a; Dako),
collagen type I (rabbit polyclonal to collagen type I; Genetek) and
apoptotic cells (rabbit anti-human active caspase-3; Cell Signalling
Technology) was performed with appropriate secondary antibody
and developed using 1% H2O2 and DAB (Sigma) in 0.05 M Tris-
HCl (pH 7.9). For the quantification of macrophages, aSMA and
collagen type I staining, photos of kidney tissue slides (magnifica-
tion x20) were taken and analyzed using ImageJ v1.47. Percentage
of positive DAP staining was related to total tissue area.
Granulocytes and apoptotic cells were counted in 10 high power
field (HPF, magnification x40). Histopathological scoring for
Periodic Acid-Schiff Diastase (PASD) stained renal tissue sections
were performed in the cortex. Criteria for measuring tubular
damage were epithelial flattening, tubular dilatation and brush
border loss. Sections were graded from 0= 0%, 1= 0–10%,
2= 10–25%, 3= 25–50%, 4= 50–75% and 5=more than 75%
damaged tubules in the cortex. Interstitial edema was estimated
using a 4-point scale: 0 = normal; 1 =mild; 2 =moderate; 3 = se-
vere and 4= extensive edema. Tubular injury and edema scoring
was performed in 10 randomly chosen, non-overlapping fields
(magnification x400).
In Situ Hybridization
Fragments of the Trem1 and Tyrobp cDNAs were obtained by
PCR using specific primers Trem1 F: 59-CACAGAGGCAG-
TCGTTGGAG, R: 59- ACATCTGAAGAACCCTTGGTCA;
Tyrobp F: 59- GTGGGAGGATTAAGTCCCGTA, R: 59- CAG-
GGAGGTACCCTGTGGAT. The PCR product was cloned into
pGEM-T-easy vector (Promega Benelux BV; Leiden, The
Netherlands) and verified by sequence analysis. Digoxigenin-11-
UTP-labeled riboprobes were synthesized from SphI or PstI
linearized plasmids by in vitro transcription reaction with T7 or
Sp6 polymerase (Roche Applied Science). After the labeling
reaction, the template DNA was digested using RQ-DNase
(Promega), and the labeled RNA probe was precipitated. The
probe was dissolved in 10 mM Tris-HCl,1 mM EDTA pH 8 and
1U RNAsin/ul and its concentration measured by Nanodrop. The
non-radioactive in situ hybridization procedure was performed, in
general, as partly described before [23]. Ten-mm-thick sections
were prepared and mounted onto coated slides. After deparaffi-
nization and hydration, sections were incubated with 20 mg/ml
proteinase K dissolved in PBS for 15 min at 37C. The proteinase
K activity was blocked by rinsing the sections in 0.2% glycine in
PBS for 5 min. After two washes in PBS for 5 min, the sections
were postfixed for 10 min in 4% PFA and 0.2% glutaraldehyde in
PBS, followed by two washes in PBS for 5 min. Before
prehybridization, a hydrophobic barrier was drawn around each
individual section using an ImmEdge pen (Vector Laboratories;
Burlingame, CA). This barrier allows treatment of each individual
section with a different RNA probe. After prehybridization for at
least 1 hr at 70C in hybridization mix (50% formamide, 5X SSC
(20X SSC; 3 M NaCl, 0.3 M tri-sodium citrate, pH 4.5), 1%
blocking solution (Roche), 5 mM EDTA, 0.1% 3–[(3-
Cholamidopropyl) dimethylammonio]-1-propanesulfonate (Sigma;
Steinheim, Germany), 0.1 mg/ml heparin (BD Biosciences;
Erembodegem, Belgium), and 1 mg/ml yeast total RNA (Roche),
a digoxigenin (DIG)-labeled probe was added to the hybridization
mix in a final concentration of 3 ng/ml. After overnight
hybridization, the sections were rinsed with 2X SSC, followed
by 2 washes with 50% formamide, 2X SSC, pH 4.5, at 65C for
30 min and 1 hour, and finally, three washes in TBS tween 0.05%
TREM1-DAP12 in UUO
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at room temperature. Subsequently, the sections were incubated
for 30 minutes with 2% blocking solution in PBS-T, followed by
overnight incubation with 2% blocking solution in PBS-T
containing 100 mU/ml anti-DIG Fab fragment covalently cou-
pled to alkaline phosphatase (AP) (Roche). Probe binding was
visualized using nitro blue tetrazolium chloride and 5-bromo-4-
chloro-3-indolyl-phosphate, toluidine-salt as the chromogenic
substrate for anti-DIG-AP, according to the manufacturer’s
protocol (Roche). After staining times of 4–6 hr at room
temperature, the color development was stopped by rinsing in
double-distilled water. The sections were dehydrated in a graded
ethanol series, rinsed in xylene, and embedded in Pertex. DAP12
and TREM1- in situ hybridization was not observed using sense
strains (data not shown).
Isolation and stimulation of primary renal tubular
epithelial cells
Primary renal tubular epithelial cells (TECs) from WT mice
were cultured as described before [11,12,20–22] and cultured in
HK2 medium in 6-wells plate until monolayer (DMEM/F12
supplemented with 10% FCS, Penicillin/streptomycin, L-gluta-
mine (all Invitrogen), 1% ITS and 1% S1 hormone mixture
(Sigma)). TECs were stimulated with 1 or 5 ng/ml recombinant
human TGF-b1(R&D systems) for 1 or 3 days.
RNA purification and rtPCR
Total RNA was isolated from 10–15 renal frozen tissue slides
(20 mM) and in vitro cell culture using Trizol reagent (Invitrogen)
according to manufacturer’s protocol. RNA samples were
quantified by spectrophotometry (Nanodrop) and converted to
cDNA using oligo-dT. mRNA expression was analyzed by RT-
PCR with SYBR green PCR master mix on a Roche LC480
lightcycler. Relative expression was analyzed using LinRegPCR
v12.4. Gene expression was correlated to housekeeping gene
(TATA-binding protein; TBP). Primer sequences: Sirpb1 forward
(F): 59-GGTGGCACTGAGTTGTTAGTCC, reverse (R): 59-
AAAGGTCACTGTCTGCTGAGG; Pilrb1 F: 59-TGGAACC-
CAACTCAACGTG, R: 59-GGATTCCTCTGGTCGCTTG;
Pilrb2 F: 59-GCACACAAGGGACAAGAGGAA, R: 59-TGCT-
GGTTCTCCATCCTGACT; Cd200r3 F: 59-TACAACCAG-
CATCCTGCCTTC, R: 59-TGCTTCTCGGAATCTCAGCAC;
Cd200r4 F: 59-CACTGTGACTGTCAGGAGCAC, R: 59-GGG-
GGTGGTCATTGTACCTT; Clec5a F: 59-TGGAGAGAAA-
AAGTGGCGCT R: 59-CTGGGCTGGTTTCAGTCACA;
Trem1 F: 59-GCGTCCCATCCTTATTACCA, R: 59-AAAC-
CAGGCTCTTGCTGAGA; Trem2 F: 59-ACCCACCTCCA-
TTCTTCTCC, R: 59-GGGTCCAGTGAGGATCTGAA;
Trem3 F: 59-AAAGCTGGGCCTAAGGTGTT, R: 59-CCCA-
GATTGTCCCCAATACA; Cd300lb F: 59-GACACGGACACT-
TACTGGTGT, R: 59-GCACCAACCAAGATGAGCAA;
AF251705 F: 59-GACCCAGTCACAGGTTCGAG, R: 59-AGA-
AGTAGAGGCTGCTCCGA; Siglech F: 59-CCATGTCTCTG-
GAAGAGTTGGT, R: 59-GTATGGGATCTCTTGCTGAG-
GA; Siglec15 F: 59-AGGCCAGCGTCTACCTGTTC, R: 59-
TGGTGATGGCTGAGGAGTTC; Tyrobp F: 59-CGAAAACA-
ACACATTGCTGA, R: 59-GGGCATAGAGTGGGCTCAT;
Treml-1 F: 59 -AGAATCGGAACCGGAAGTCT, R: 59 -GG-
CCATCACAGCAAATATCA; Treml-2 F: 59-CACCTGTG-
GTGTTGGTCGTA, R: 59-CCTTCTGAACCCACTGGAAA;
Treml-4 F: 59-ATGGACTCCTCCTGCTCAAG, R: 59-AGAT-
GTGGCTAACCGTGTCC, Tlr2 F: 59-GGGGCTTCACTTC-
TCTGCTT, R: 59-AGCATCCTCTGAGATTTGACG, Tlr4 F:
59 -GGACTCTGATCATGGCACTG, R: 59-CTGATCCATG-
CATTGGTAGGT and TBP F: 59-GGAGAATCATGGACCA-
GAACA, R: 59-GATGGGAATTCCAGGAGTCA.
ELISA and Western Blot
For ELISA, snap-frozen kidney part was homogenized in
Greenberger Lysis buffer (300 mM NaCl, 15 mM Tris, 2 mM
MgCl, 1 mM CaCl2 and 1% Triton X100, pH 7.4 with 100 mg/
ml pepstatin A, leupeptin and aprotinin mix), incubated for 30
minutes at 4uC, centrifuged at 1500 g and stored in280uC. Levels
of keratineocyte-derived cytokine (KC), monocyte chemotactic
protein (MCP)-1 and transforming growth factor (TGF)-b1 (all
R&D Systems) were measured in kidney homogenate according to
manufacturer’s instructions. Protein levels were corrected for total
protein level present in sample using BioRad protein assay
(BioRad Laboratories) with IgG as standard. For western blot,
kidney lysates were prepared from 15 frozen sections (30 mm thick)
or from primary TEC in culture, incubated at 4uC for 30 min in
RIPA buffer containing 50 mM Tris pH7.5, 0.15 M NaCl, 2 mM
EDTA, 1% deoxycholic acid, 1% NP-40, 4 mM sodium
orthovanadate, 10 mM sodium fluoride, 1% protease inhibitor
cocktail (P8340, Sigma). The lysates were then centrifuged at
12000 rpm for 15 minutes and the supernatants were collected
and stored at 220uC. SDS-polyacrylamide gel electrophoresis was
carried out in 10% gradient slab gels and proteins were
electrophoretically transferred onto methanol-activated polyviny-
lidene fluoride (PVDF) microporous membranes (Millipore, Etten
Leur, The Netherlands). Membranes were blocked for one hour
with 5% bovine serum albumin (Sigma) in Tris-buffered saline
containing 0.1% Tween 20 (TBS-T), followed by overnight
incubation at 4uC with primary rabbit anti-mouse/human
TREM1 (Abcam ab104413, Cambridge, UK). HRP-conjugated
secondary antibodies (DAKO, Glostrup, Denmark) were incubat-
ed for one hour at room temperature, and HRP activity was
visualized with ECL-reagent (Amersham Pharmacia Biotech,
Roosendaal, The Netherlands. b-actin was used as loading control
and detected by mouse IgG1 anti-b-actin (Abcam, Cambridge,
UK). Densitometric quantification analysis was performed on
imagines of scanned films using the image processing program
ImageJ (National Institute of Health, US).
Statistical analysis
Comparison between .2 groups was analyzed using Kruskal-
Wallis test followed by Dunn’s Multiple Comparison test. Level of
significance between 2 groups was determined by Mann-Whitney.
Data are expressed as mean6 standard deviation (SD). Eight mice
per group were analyzed at every time point. P,0.05 was
considered statistically significant.
Results
TREM1 expressing cells in hydronephrosis
Renal fibrosis is characterized by accumulation of interstitial
leukocytes and myofibroblasts, induction of inflammation with
eventual tubular atrophy and loss of renal function. Fibrosis and
tubular atrophy are characteristic features of hydronephrosis.
TREM1 expression has never been reported in human kidney
disease and could contribute in inflammatory processes during
hydronephrosis. In renal tissue from patients with hydronephrosis,
TREM1 was expressed on tubulointerstitial cells (figure 1) which
was not detectable in renal biopsies from renal transplant patients
with stable graft.
TREM1-DAP12 in UUO
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TREM1-DAP12 expression upon murine UUO
Murine UUO is a frequently used model which represents
progressive renal injury and fibrosis and has the same pathology as
hydronephrosis. We screened for DAP12 and TREM1 mRNA
levels in kidneys from WT mice following UUO. DAP12 and
especially TREM1 mRNA levels significantly increased following
UUO with highest expression at day 14 (DAP12: 18-fold and
TREM1: 800-fold compared to control; figure 2). In situ
hybridization showed that DAP12- and TREM1-mRNA positive
tubulointerstitial cells are present upon UUO which was not
present in control kidneys. Following UUO, TREM1 expression
also increased on protein level, especially 14 days after UUO
(figure 2C). TREM1 expression was not observed in kidneys from
TREM1/3 KO mice (data not shown). Increased renal TREM1
expression could originate from infiltrating TREM1-expressing
myeloid cells or, although yet unknown, upregulation of TREM1
on renal cells like TECs. In vitro studies showed that DAP12 and
TREM1 mRNA level in TECs were low and remained similar
upon stimulation with 1 or 5 ng/ml TGF-b1for 1 or 3 days (data
not shown). In addition, we showed TREM1 expression on protein
level on TECs which remained similar upon stimulation with 1 or
5 ng/ml TGF-b1for 3 days (figure S1).
TREM (like) family and TLR expression in WT, TREM1/3 KO
and DAP12 KO mice
The murine family of TREM receptors includes Trem1,
Trem2, Trem3 and Trem-like transcript (Treml) -1, -2 and -4.
We screened these genes in TREM1/3 KO mice (and DAP12 KO
mice) to exclude any potential compensation of these genes due to
mutation in KO mice. Renal mRNA levels of TREM2, Trem-like
transcript (Treml) -1, -2 and -4 were similar between WT,
TREM1/3 KO and DAP12 KO mice in control kidneys (data not
shown). TREM1-DAP12 pathway is involved in modulating the
TLR-signaling cascade, most likely TLR2 and TLR4 [24]. We
next investigated TLR2 and TLR4 expression in WT, TREM1/3
Figure 1. TREM1 expression and localization during hydronephrosis. TREM1 expression on renal biopsies from renal transplant patients
with stable graft function (A) and from patients with obstructive hydronephrosis (B+C). Arrow indicates examples of TREM1-positive cells. Inserts
display enlargement of TREM1-positive cells. Magnification x20.
doi:10.1371/journal.pone.0082498.g001
Figure 2. Renal levels of DAP12 and TREM1 upon UUO. Frozen kidney sections were cut and dissolved in TRIzol (A+B) or RIPA buffer (C) to
isolate RNA and protein respectively. Renal mRNA levels of DAP12 (A) and TREM1 (B) were determined in WT mice, 1, 3, 7 and 14 days following UUO.
Contralateral unobstructed kidney 1 day after UUO was used as control (C1). Gene expression is relatively expressed to housekeeping gene TBP and
control is adjusted to relative expression of 1. (C): representative TREM1 western blot (WB) of kidney tissue in control WT mice (C1), 7 (U7) and 14
(U14) days after UUO. Ten mg of total protein was loaded in each lane. Values below WB indicate TREM1 protein densitometric quantification
normalized to loading control b-actin and control (C1) was set to 1. *P,0.001, **P,0.0005 vs. control. DAP12 (D+E) and TREM1 (F+G) in situ
hybridization was performed on renal paraffin section from WT mice 14 days following UUO. Contralateral unobstructed kidney 1 day after UUO was
used as control. Arrows indicate example of positive cells. Inserts display enlargement of positive cells. Magnification x40.
doi:10.1371/journal.pone.0082498.g002
TREM1-DAP12 in UUO
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Figure 3. TLR2 and TLR4 expression upon UUO in WT, TREM1/3 KO and DAP12 KOmice. Frozen kidney sections were cut and dissolved in
TRIzol to isolate RNA. Renal mRNA levels of TLR2 (A) and TLR4 (B) were determined in WT (black bars), TREM1/3 KO (white bars) and DAP12 KO (grey
bars) 1, 3, 7 and 14 days following UUO. Contralateral unobstructed kidney 1 day after UUO was used as control (C1). Gene expression is relatively
expressed to housekeeping gene TBP and control is adjusted to relative expression of 1. *P,0.05, **P,0.01 versus WT at indicated time point.
doi:10.1371/journal.pone.0082498.g003
Figure 4. Inflammation upon UUO in WT, TREM1/3 KO and DAP12 KO mice. Renal tissue was processed to determine KC (A) and MCP1 (B)
expression, granulocyte (C) and macrophage (D) influx in WT (black bars), TREM1/3 KO (white bars) and DAP12 KO (grey bars) mice 1, 3, 7 and 14 days
following UUO. Contralateral unobstructed kidney 1 day after UUO was used as control (C1). Ly6G cells were counted per high power field (HPF,
magnification x400). F4/80 staining is expressed as % positive staining per HPF, magnification x20. *P,0.05, **P,0.01 versus WT at indicated time
point. Pictures are representative photographs of F4/80 IHC staining of kidney tissue slides from WT, TREM1/3 KO and DAP12 KO mice, 7 days
following UUO (magnification x20).
doi:10.1371/journal.pone.0082498.g004
TREM1-DAP12 in UUO
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Figure 5. Renal fibrosis markers upon UUO. Renal tissue was processed to determine TGF-b1expression in kidney homogenate (A) and aSMA (B)
and collagen type I (B) staining on kidney tissue slides in WT (black bars), TREM1/3 KO (white bars) and DAP12 KO (grey bars) 1, 3, 7 and 14 days
following UUO. TGF-b1is corrected for total protein level per sample. aSMA and collagen type I staining is expressed as % positive staining per high
power field. Contralateral unobstructed kidney 1 day after UUO was used as control (C1). *P,0.05 versus WT at indicated time point.
doi:10.1371/journal.pone.0082498.g005
TREM1-DAP12 in UUO
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KO and DAP12 KO mice following UUO. In WT mice following
UUO, renal TLR2 mRNA (day 3, 7 and 14) and TLR4 mRNA
(day 7 and 14) increased significantly compared to control as
described earlier [11][12], (figure 3, statistics not displayed). Renal
TLR2 and TLR4 mRNA increased similar in all three groups
following UUO except for reduced TLR2 mRNA levels in
TREM1/3KO and DAP12 KOmice, 7 days after UUO (figure 3).
Inflammation in WT, TREM1/3 KO and DAP12 KO mice
upon UUO
Typically, progressive renal injury is characterized by produc-
tion of chemokines and recruitment of inflammatory cells
including macrophages and granulocytes [11][12]. In WT mice
following UUO renal KC (day 1 and 3) and MCP1, Ly6G staining
and F4/80 staining (all day 7 and 14) increased significantly
compared to their control (figure 4; statistics not displayed).
Compared to WT mice, DAP12 KO mice displayed less renal KC
and MCP-1 levels (figure 4A+B, day 7 and 14) and reduced level
of macrophages 7 days after UUO (figure 4D). TREM1/3 KO
mice displayed less renal MCP-1 levels 14 days after UUO
(figure 4B). The number of infiltrating granulocytes progressively
increased upon UUO over time and displayed similar pattern in
WT, TREM1/3 and DAP12 KO mice (figure 4C).
Fibrosis marker upon UUO
To establish the effect of TREM1/3 and DAP12 deficiency on
the development of fibrosis we measured renal TGFb, accumu-
lation of aSMA expressing cells and collagen type I deposition. In
WT mice following UUO renal TGF-b1, aSMA staining and
Collagen 1 staining (all day 3, 7 and 14) increased significantly
compared to control (figure 5; statistics not displayed). Compared
to WT mice, DAP12 KO mice displayed less renal TGF-b1 levels,
7 days after UUO (figure 5A). The accumulation of aSMA
expressing cells and collagen type I deposition increased similar in
WT, TREM1/3 KO and DAP12 KO mice (figure 5B+C).
Tubular injury and interstitial edema upon UUO
We counted apoptotic TECs and scored tubular damage and
edema on renal tissue sections. Presence of caspase3+ TECs was
observed especially 7 and 14 days after UUO and numbers were
not significantly different between groups (data not shown). In WT
mice, tubular injury (as depicted by PASD score) significantly
increased 3, 7 and 14 days after UUO compared to day 1 (figure 6;
statistics not displayed). A small but significant increase in tubular
damage was observed in TREM1/3 KO (day 1) and DAP12 KO
mice (day 1+3) compared to WT mice which was in line with
enhanced interstitial edema in these mice (figure 6).
Other DAP12-associated receptors
TREM1/3 KO mice displayed only partly similar phenotype
compared to DAP12 KO mice. Possibly, also other DAP12-
associated receptors contribute to the induction of inflammation
upon UUO. We screened for other DAP12-associated myeloid
receptors including Sirpb1 (signal-regulatory protein beta 1A),
Pilrb1+2 (paired immunoglobin-like type 2 receptor beta),
Cd200r3, CD200r4, Clec5a (C-type lectin domain family 5,
member a), Trem2, Trem3, Cd300lb (CD300 antigen like family
member B), AF251705 (cDNA sequence AF251705 known as
MAIR-II), Siglech (sialic acid binding Ig-like lectin H) and
Siglec15[25]. Renal mRNA levels of mentioned DAP12-associated
myeloid receptors all gradually increased upon UUO with highest
expression at day 14 (figure 7). In order of magnitude, 14 days
Figure 6. Tubular injury and edema upon UUO. Kidney tissue slides were cut and quantified for PASD (A) and edema score (B) in WT (black
bars), TREM1/3 KO (white bars) and DAP12 KO (grey bars) mice following UUO. PASD score was graded according to % of damaged tubuli on an
increasing 5-point scale (see methods section). Interstitial edema score was graded according to severity on an increasing 4-point scale (see methods
section). *P,0.05, **P,0.01 versus WT at indicated time point. Pictures are representative photographs of PASD staining of kidney tissue slides from
WT, TREM1/3 KO and DAP12 KO mice, 3 days following UUO (magnification x20).
doi:10.1371/journal.pone.0082498.g006
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after UUO renal mRNA levels of Siglech (7.2-fold), Sirpb (8,1-
fold), Siglec15 (8,9-fold), Trem3 (16,1-fold), AF251705 (21,5-fold),
Pilrb1 (21,6-fold), Clec5a (22,2-fold), Cd300lb (28,9-fold), Pilrb2
(30,1-fold), Cd200r3 (35,7-fold), Cd200r4 (80,1-fold) and Trem2
(80,6-fold) were significantly increased compared to control
(P,0.005 to P,0.0005 vs. control). It remains to be investigated
which, next to TREM1, DAP12-associated receptors contributes
to inflammation upon UUO.
Discussion
Tubulo-interstitial damage is characterized by inflammation
and myofibroblast accumulation with excessive deposition of
extracellular matrix (ECM) [2–5]. Inflammatory response can be
triggered by TREM1-DAP12 pathway activation through ampli-
fication of TLR-signaling. Whereas the contribution of TLRs in
obstructive nephropathy is known, the contribution of TREM1-
DAP12 herein is not. We showed that TREM1-expressing cells
infiltrate kidney tissue from patients suffering obstructive nephrop-
athy. In mice, DAP12 and especially TREM1 expression
increased during progression of UUO. DAP12, partly through
TREM1/3, contributes to inflammation during progression of
UUO but does not affect fibrosis.
TREM1 expression has been reported in several human
myeloid and non-myeloid cells and in inflamed human lung, skin
and intestinal tissue [26–30] and is expressed to a lesser extend on
lymphocytes [28]. To our knowledge we are the first to report
TREM1 expression in kidney disease. These TREM1 positive
cells could contribute to the magnitude of inflammation and
TREM1-DAP12 signaling and was therefore further investigated
using TREM1/3 KO and DAP12 KO mice. TREM1 KO and
TREM1/3 KO mice were described only very recently [18] and
so far, studies on TREM1 signaling were generally performed
using agonistic or inhibitory antibodies and/or peptides.
TREM1-DAP12 signaling was shown to be important in
modulating the innate immune response, most likely by amplifying
TLR-induced inflammation. TREM1-DAP12 is known to be
involved in magnitude of inflammation during sepsis and bacterial
infections [9][31]. However, the contribution of TREM1-DAP12
during tissue injury is limited. Inhibition of TREM1 reduced
Figure 7. Renal mRNA levels of DAP12-associated myeloid receptors upon UUO. Frozen kidney sections were cut and dissolved in TRIzol to
isolate RNA. Renal mRNA levels of Siglech, Sirpb, Siglec15, Trem3, AF251705, Pilrb1, Clec5a, Cd300lb, Pilrb2, Cd200r3, Cd200r4 and Trem2 were
determined in WT mice, 1, 3, 7 and 14 days following UUO. Contralateral unobstructed kidney 1 day after UUO was used as control (C1). Genes are
presented top-left to bottom-right in order of magnitude (expression on day 14 compared to control). Gene expression is relatively expressed to
housekeeping gene TBP and group C1 is adjusted to relative value of 1. *P,0.01, **P,0.005, ***P,0.001, ****P,0.0005 vs. control.
doi:10.1371/journal.pone.0082498.g007
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inflammatory symptoms and improved survival during mesenteric
ischemia-reperfusion injury and hemorrhagic shock [32][33].
Similar, pretreatment with TREM1 inhibitor improved the
hepatic and renal dysfunction in experimental model of severe
acute pancreatitis [34]. A study by Lech et al. reported enhanced
TREM1 and DAP12 mRNA levels following renal IR and UUO
but so far, no studies about the contribution of TREM1-DAP12
signaling in kidney diseases are known [35]. We showed that
DAP12 mRNA and TREM1 mRNA/protein levels are elevated
14 days after induction of UUO (figure 2). We believe that
increased levels most likely originate from infiltration and
activation of TREM1-DAP12 expressing cells like granulocytes
and macrophages [36] and not from increased expression on renal
cells like TECs. So far, we were unsuccessful in localizing TREM1
or DAP12 positive cells on murine renal tissue sections using
immunohistochemistry with commercially available antibodies
(data not shown). Although a specific ligand for TREM1 is
unknown, endogenous DAMPs like HSP70 and HMGB1 have
been suggested [10]. Of these two candidates, HMGB1, but not
HSP70, is known to be upregulated during progression of UUO
[11,12,37]. HMGB1 is also a well known TLR ligand and it
remains to be investigated if HMGB1 signals through TREM1/3
and/or TLR during UUO.
During later phase of UUO, TREM1/3 KO and especially
DAP12 KO mice displayed reduced levels of renal chemokines
compared to WT mice showing that DAP12 signaling, partly
through TREM1/3, contributes to renal inflammation upon
progression of UUO (figure 4). The delayed macrophage influx in
DAP12 KO mice could be related to lower renal levels of MCP1.
Otherwise, delayed macrophage influx could be related to intrinsic
feature of DAP12 deficient macrophages; DAP12-deficient mac-
rophages are known to have a reduced migration capacity towards
MCP1 [38]. But at day 14, macrophage influx was similar between
WT and DAP12 KO mice, despite differences in renal MCP1
level making the latter hypothesis less likely. The exact reason for
the delayed macrophage influx remains speculative. The alter-
ations in inflammation in TREM1/3 KO and DAP12 KO mice
did not affect development of fibrosis given that myofibroblast
accumulation and collagen deposition increased similarly in all
three groups (figure 5). In addition, tubular apoptosis and renal
damage increased similarly in all three groups during progression
of UUO. However, early after UUO, tubular damage was slightly
higher in TREM1/3 KO mice (day 1) and DAP12 KO mice (day
1+3) which was in line with more edema in these mice (figure 6).
Enhanced tubular damage upon UUO was also observed in TLR4
KO mice [12], possibly because of TLR4 involvement in
regulation of adhesion molecules by fibroblasts, epi- and endo-
thelial cells and its role in tubular architecture and integrity [39–
41]. TREM1 has been described to interact with TLR4 [42][24]
and we showed TREM1 expression on murine TECs. Possibly,
similar mechanisms may play part in enhanced tubular damage in
TREM1/3 KO mice as seen in TLR4 KO mice but this remains
to be investigated in future.
During UUO, TREM1/3 KO mice displayed only partial
similar phenotype compared to DAP12 KO mice. This implicates
that other DAP12-related receptors might be involved, for
instance Sirpb1, Pilrb, Cd200r3+4, Clec5a, TREM2, Cd300lb,
AF251705 (MAIR-II), Siglec-h, and Siglec15 (reviewed in [25]). In
a screening for these DAP12 associated myeloid receptors upon
UUO, we observed increased mRNA levels of all mentioned genes
(figure 7). Earlier studies have shown that Cd300lb[43], Pilrb[44],
Clec5a[45][46], MAIR-II[47], Siglec-h[48], Siglec-15[49] are
involved in induction of inflammation. So far, only the contribu-
tion of DAP12-associated myeloid receptors Cd300lb (commonly
described as LMIR5) has been investigated in renal diseases
showing that LMIR5 deficiency ameliorates mouse kidney IRI
[50]. LMIR5 deficient mice displayed less renal inflammatory
mediators, including MCP1, neutrophil influx and renal damage
following IR [50]. If LMIR-5, or other DAP12-associted receptors
except for TREM1/3, play part in UUO remains to be
investigated and is beyond the scope of this paper. In conclusion,
our results show that DAP12, partly through TREM1/3, is
involved in renal inflammation during progression of UUO
whereas TREM1-DAP12 does not play part in renal fibrosis.
Supporting Information
Figure S1 TREM1 protein expression on TEC. Primary
TECs were isolated, cultured and TREM1 protein expression was
determined by western blot. TECs from WT mice were stimulated
with 1 or 5 ng TGF-b1/ml medium for 3 days. Cell lysates were
obtained and quantified for TREM1 protein expression (A).
Densometric quantification analysis of western blot is displayed in
B, control was set to 1. Data are mean 6 SD, N=2 per group.
AU=arbitrary units.
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